TY - JOUR
T1 - The spatially resolved transcriptional profile of acute T cell–mediated rejection in a kidney allograft
AU - Salem, Fadi
AU - Perin, Laura
AU - Sedrakyan, Sargis
AU - Angeletti, Andrea
AU - Ghiggeri, Gian Marco
AU - Coccia, Maria Cristina
AU - Ross, Marty
AU - Fribourg, Miguel
AU - Cravedi, Paolo
N1 - Funding Information:
The study was supported by a grant from the Renal Research Institute , New York, NY. MF was supported by the National Institute of Allergy and Infectious Diseases grant R01 AI141710 .
Publisher Copyright:
© 2021 International Society of Nephrology
PY - 2022/1
Y1 - 2022/1
N2 - Analysis of the transcriptional profile of graft biopsies represents a promising strategy to study T cell–mediated-rejection (TCMR), also known as acute cellular rejection. However, bulk RNA sequencing of graft biopsies may not capture the focal nature of acute rejection. Herein, we used the whole exome GeoMX Digital Space Profiling platform to study five tubular and three glomerular regions of interest in the kidney graft biopsy from a patient with a chronic-active TCMR episode and in analogous areas from two different normal kidney control biopsies. All kidney sections were from paraffin blocks. Overall, inflammatory genes were significantly upregulated in the tubular areas of the TCMR biopsy and showed an enrichment for gene-ontology terms associated with T-cell activation, differentiation, and proliferation. Enrichment analysis of the 100 genes with the highest coefficient of variation across the TCMR tubular regions of interest revealed that these highly variable genes are involved in kidney development and injury and interestingly do not associate with the 2019 Banff classification pathology scores within the individual regions of interest. Spatial transcriptomics allowed us to unravel a previously unappreciated variability across different areas of the TCMR biopsy related to the graft response to the alloimmune attack, rather than to the immune cells. Thus, our approach has the potential to decipher clinically relevant, new pathogenic mechanisms, and therapeutic targets in acute cellular rejection and other kidney diseases with a focal nature.
AB - Analysis of the transcriptional profile of graft biopsies represents a promising strategy to study T cell–mediated-rejection (TCMR), also known as acute cellular rejection. However, bulk RNA sequencing of graft biopsies may not capture the focal nature of acute rejection. Herein, we used the whole exome GeoMX Digital Space Profiling platform to study five tubular and three glomerular regions of interest in the kidney graft biopsy from a patient with a chronic-active TCMR episode and in analogous areas from two different normal kidney control biopsies. All kidney sections were from paraffin blocks. Overall, inflammatory genes were significantly upregulated in the tubular areas of the TCMR biopsy and showed an enrichment for gene-ontology terms associated with T-cell activation, differentiation, and proliferation. Enrichment analysis of the 100 genes with the highest coefficient of variation across the TCMR tubular regions of interest revealed that these highly variable genes are involved in kidney development and injury and interestingly do not associate with the 2019 Banff classification pathology scores within the individual regions of interest. Spatial transcriptomics allowed us to unravel a previously unappreciated variability across different areas of the TCMR biopsy related to the graft response to the alloimmune attack, rather than to the immune cells. Thus, our approach has the potential to decipher clinically relevant, new pathogenic mechanisms, and therapeutic targets in acute cellular rejection and other kidney diseases with a focal nature.
KW - biopsy
KW - kidney transplant
KW - spatial transcriptomic
UR - http://www.scopus.com/inward/record.url?scp=85118589701&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2021.09.004
DO - 10.1016/j.kint.2021.09.004
M3 - Article
C2 - 34555393
AN - SCOPUS:85118589701
VL - 101
SP - 131
EP - 136
JO - Kidney International
JF - Kidney International
SN - 0085-2538
IS - 1
ER -